These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35568197)

  • 1. Key dimer interface residues impact the catalytic activity of 3CLpro, the main protease of SARS-CoV-2.
    Ferreira JC; Fadl S; Rabeh WM
    J Biol Chem; 2022 Jun; 298(6):102023. PubMed ID: 35568197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pH profiles of 3-chymotrypsin-like protease (3CLpro) from SARS-CoV-2 elucidate its catalytic mechanism and a histidine residue critical for activity.
    Al Adem K; Ferreira JC; Fadl S; Rabeh WM
    J Biol Chem; 2023 Feb; 299(2):102790. PubMed ID: 36509143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-range cooperative interactions modulate dimerization in SARS 3CLpro.
    Barrila J; Bacha U; Freire E
    Biochemistry; 2006 Dec; 45(50):14908-16. PubMed ID: 17154528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and biophysical characterization of the main protease, 3-chymotrypsin-like protease (3CLpro) from the novel coronavirus SARS-CoV 2.
    Ferreira JC; Rabeh WM
    Sci Rep; 2020 Dec; 10(1):22200. PubMed ID: 33335206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro): IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS.
    Tomar S; Johnston ML; St John SE; Osswald HL; Nyalapatla PR; Paul LN; Ghosh AK; Denison MR; Mesecar AD
    J Biol Chem; 2015 Aug; 290(32):19403-22. PubMed ID: 26055715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimethyl sulfoxide reduces the stability but enhances catalytic activity of the main SARS-CoV-2 protease 3CLpro.
    Ferreira JC; Fadl S; Ilter M; Pekel H; Rezgui R; Sensoy O; Rabeh WM
    FASEB J; 2021 Aug; 35(8):e21774. PubMed ID: 34324734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric Regulation and Inhibition of Coronavirus 3CLpro Revealed by HDX-MS.
    Song N; Zheng W; Song B; Zheng J
    Chembiochem; 2024 Jul; 25(13):e202400001. PubMed ID: 38720172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key Allosteric and Active Site Residues of SARS-CoV-2 3CLpro Are Promising Drug Targets.
    Al Adem K; Ferreira JC; Fadl S; Mustafa M; Rabeh WM
    Biochem J; 2023 May; ():. PubMed ID: 37254750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catalytic Dyad Residues His41 and Cys145 Impact the Catalytic Activity and Overall Conformational Fold of the Main SARS-CoV-2 Protease 3-Chymotrypsin-Like Protease.
    Ferreira JC; Fadl S; Villanueva AJ; Rabeh WM
    Front Chem; 2021; 9():692168. PubMed ID: 34249864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease.
    Chiou WC; Chen JC; Chen YT; Yang JM; Hwang LH; Lyu YS; Yang HY; Huang C
    Biochem Biophys Res Commun; 2022 Feb; 591():130-136. PubMed ID: 33454058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300.
    Davis DA; Bulut H; Shrestha P; Yaparla A; Jaeger HK; Hattori SI; Wingfield PT; Mieyal JJ; Mitsuya H; Yarchoan R
    mBio; 2021 Aug; 12(4):e0209421. PubMed ID: 34399606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy.
    Goyal B; Goyal D
    ACS Comb Sci; 2020 Jun; 22(6):297-305. PubMed ID: 32402186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competitive Interaction of the SGFRKMAF Peptide with 3CLpro Dimerization Intermediates: A Brownian Dynamics Investigation.
    ElSawy KM
    J Phys Chem B; 2024 Aug; 128(30):7313-7321. PubMed ID: 39028939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visualizing the Active Site Oxyanion Loop Transition Upon Ensitrelvir Binding and Transient Dimerization of SARS-CoV-2 Main Protease.
    Kovalevsky A; Aniana A; Coates L; Ghirlando R; Nashed NT; Louis JM
    J Mol Biol; 2024 Jul; 436(13):168616. PubMed ID: 38762033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-Based High-Throughput Screening Protocol for Discovering Antiviral Inhibitors Against SARS-COV-2 Main Protease (3CLpro).
    Rothan HA; Teoh TC
    Mol Biotechnol; 2021 Mar; 63(3):240-248. PubMed ID: 33464543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Host Cellular Protein Substrates of SARS-COV-2 Main Protease.
    Miczi M; Golda M; Kunkli B; Nagy T; Tőzsér J; Mótyán JA
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33333742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism for controlling the dimer-monomer switch and coupling dimerization to catalysis of the severe acute respiratory syndrome coronavirus 3C-like protease.
    Shi J; Sivaraman J; Song J
    J Virol; 2008 May; 82(9):4620-9. PubMed ID: 18305031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease cleavage of RNF20 facilitates coronavirus replication via stabilization of SREBP1.
    Zhang S; Wang J; Cheng G
    Proc Natl Acad Sci U S A; 2021 Sep; 118(37):. PubMed ID: 34452991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a colorimetric assay for the detection of SARS-CoV-2 3CLpro activity.
    Garland GD; Harvey RF; Mulroney TE; Monti M; Fuller S; Haigh R; Gerber PP; Barer MR; Matheson NJ; Willis AE
    Biochem J; 2022 Apr; 479(8):901-920. PubMed ID: 35380004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residues on the dimer interface of SARS coronavirus 3C-like protease: dimer stability characterization and enzyme catalytic activity analysis.
    Chen S; Zhang J; Hu T; Chen K; Jiang H; Shen X
    J Biochem; 2008 Apr; 143(4):525-36. PubMed ID: 18182387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.